During the past decade, University of Maryland, Institute of Human Virology conducted 17 clinical trials. In the 10-year time frame, 17 clinical trials started and 20 clinical trials were completed, i.e. on average, 117.6% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 9 clinical trials were completed. i.e. 128.6% of trials that started reached the finish line.

Out of the total clinical trials conducted in "University of Maryland, Institute of Human Virology" #1 sponsor was "National Institute of Allergy and Infectious Diseases (NIAID)" with 24 trials, followed by "University of Maryland, Baltimore" with 12 trials sponsored, "AIDS Clinical Trials Group" with 11 trials sponsored, "Gilead Sciences" with 4 trials sponsored and "Johns Hopkins University" with 4 trials sponsored. Other sponsors include 15 different institutions and companies that sponsored additional 20 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "University of Maryland, Institute of Human Virology" #1 collaborator was "National Institute of Allergy and Infectious Diseases (NIAID)" with 14 trials as a collaborator, "AIDS Clinical Trials Group" with 3 trials as a collaborator, "Adult AIDS Clinical Trials Group" with 3 trials as a collaborator, "Merck Sharp & Dohme LLC" with 3 trials as a collaborator and "Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)" with 2 trials as a collaborator. Other collaborators include 22 different institutions and companies that were collaborators in the rest 31 trials.

According to Clinical.Site data, the most researched conditions in "University of Maryland, Institute of Human Virology" are "HIV Infections" (48 trials), "HIV" (5 trials), "HIV Infection" (4 trials), "HIV-1 Infection" (4 trials) and "Chronic Hepatitis B" (3 trials). Many other conditions were trialed in "University of Maryland, Institute of Human Virology" in a lesser frequency.

Most popular intervention types in "University of Maryland, Institute of Human Virology" are "Drug" (54 trials), "Biological" (10 trials), "Other" (5 trials), "Procedure" (2 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (6 trials), "Efavirenz" (5 trials), "Ritonavir" (5 trials), "Raltegravir" (4 trials) and "Stavudine" (4 trials). Other intervention names were less common.

The vast majority of trials in "University of Maryland, Institute of Human Virology" are 69 trials for "All" genders, 4 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "University of Maryland, Institute of Human Virology". undefined are not yet recruiting, 4 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 56 completed trials in University of Maryland, Institute of Human Virology, undefined suspended trials, and 6 terminated clinical trials to date.

Out of the total trials that were conducted in University of Maryland, Institute of Human Virology, 11 "Phase 1" clinical trials were conducted, 20 "Phase 2" clinical trials and 15 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 6 trials, and there were also 14 trials that are defined as “Not Applicable".